Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia

Effectiveness of the uPatient Platform in the Fulfillment of the Prophylactic Treatment in Patients With Hemophilia

Research project whose main objective is to evaluate the use of a technology platform (uPatient) to register the prophylactic treatment of patients with hemophilia treated in different Hematology and Hemotherapy services of several hospitals in Spain.

The data obtained in this project will identify the level of compliance to the pharmacological treatment of patients with hemophilia prophylaxis. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for patients with hemophilia. Clinical data were also obtained regarding the joint of patients participating in the study state.

Inclusion Criteria:

• Patients diagnosed with hemophilia A or B
• Patients over 13 years old
• Patients on prophylactic treatment.

Exclusion Criteria:

• Patients who do not sign the informed consent document
• Patients who do not make domiciliary self-treatment
• Patients who do not have good adhesion to prophylactic treatment